Vijaya Diagnostic Centre enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
15,066————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
268268197131163
0.00.03.42.71.9
14,798————
−268−268−197−131−163
₹1,438.15————
957957799660547
17.26×————
40.89×————
55.66×————
168.40×————
Reference items — trailing FY values
857814681548459
362337273221182
266245203164120
—271224183165
87.987.912995.339.8
—80.012289.439.8
—18395.688.0125
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

VIJAYA₹1,464.20

Vijaya Diagnostic Centre Ltd.

· Pharma & Health
₹ CrorePeersTHYROCAREMETROPOLISLALPATHLABRAINBOWPOLYMEDPFIZERONESOURCEKIMSMcap ₹15,066 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————15,066.2
- Cash, Equiv & ST Investments163.2131.4197.4268.1268.1
+ Minority Interest1.92.73.40.00.0
Enterprise Value————14,798.1
Net Debt (memo)-163.2-131.4-197.4-268.1-268.1
EV per Share————1,438.15
Total Capital546.6659.9799.1957.2957.2
EV/Sales————17.26
EV/EBITDA————40.89
EV/EBIT————55.66
EV/Free Cash Flow————168.40
Reference Items — Trailing FY Values
Sales459.2547.8681.4814.2857.1
EBITDA182.0220.9273.2336.9361.9
EBIT120.3163.9202.6245.1265.9
Operating Cash Flow164.6183.3224.5270.6—
Free Cash Flow39.895.3128.987.987.9
FCFF (free cash flow to the firm)39.889.4122.180.0—
Capital Expenditure124.888.095.6182.7—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.